Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlotte Cunningham-Rundles

Showing results (201-210 of 289) with videos related to

Pageof 29
Sort By:
Science Immunology|October 4, 2024
Maintenance of X chromosome inactivation after T cell activation requires NF-κB signalingKatherine S Forsyth, Natalie E Toothacre, Nikhil Jiwrajka, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
NF-κB Signaling is Required for X-Chromosome Inactivation Maintenance Following T cell ActivationKatherine S Forsyth, Natalie E Toothacre, Nikhil Jiwrajka, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2011
Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humansGreta Meyers, Yen-Shing Ng, Jason M Bannock, et al.
JCI Insight|March 23, 2026
Heterozygous NFKB1 variant causes inflammatory dysregulation shaped by broader genetic context in common variable immunodeficiencyKevin M Hayes, Kai Boldt, Peter J Schnorr, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 14, 2015
International Consensus Document (ICON): Common Variable Immunodeficiency DisordersFrancisco A Bonilla, Isil Barlan, Helen Chapel, et al.
The Journal of Clinical Investigation|September 21, 2013
CVID-associated TACI mutations affect autoreactive B cell selection and activationNeil Romberg, Nicolas Chamberlain, David Saadoun, et al.
Thrombosis and Haemostasis|December 24, 2024
Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP SummitDimpy Modi, Saifur R Chowdhury, Syed Mahamad, et al.
The Journal of Allergy and Clinical Immunology|April 19, 2011
Genome-wide association identifies diverse causes of common variable immunodeficiencyJordan S Orange, Joseph T Glessner, Elena Resnick, et al.
British Journal of Haematology|October 11, 2011
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patientsDelphine Gobert, James B Bussel, Charlotte Cunningham-Rundles, et al.
Journal of Human Immunity|May 22, 2026
A systematic literature review of CVID reveals pervasive detrimental noninfectious manifestationsG Michelle Ducasa, Rebecca A Marsh, Ali Mojebi, et al.
Pageof 29

Showing results (201-210 of 289) with videos related to

Sort By:
Pageof 29
Science Immunology|October 4, 2024
Maintenance of X chromosome inactivation after T cell activation requires NF-κB signalingKatherine S Forsyth, Natalie E Toothacre, Nikhil Jiwrajka, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
NF-κB Signaling is Required for X-Chromosome Inactivation Maintenance Following T cell ActivationKatherine S Forsyth, Natalie E Toothacre, Nikhil Jiwrajka, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2011
Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humansGreta Meyers, Yen-Shing Ng, Jason M Bannock, et al.
JCI Insight|March 23, 2026
Heterozygous NFKB1 variant causes inflammatory dysregulation shaped by broader genetic context in common variable immunodeficiencyKevin M Hayes, Kai Boldt, Peter J Schnorr, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 14, 2015
International Consensus Document (ICON): Common Variable Immunodeficiency DisordersFrancisco A Bonilla, Isil Barlan, Helen Chapel, et al.
The Journal of Clinical Investigation|September 21, 2013
CVID-associated TACI mutations affect autoreactive B cell selection and activationNeil Romberg, Nicolas Chamberlain, David Saadoun, et al.
Thrombosis and Haemostasis|December 24, 2024
Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP SummitDimpy Modi, Saifur R Chowdhury, Syed Mahamad, et al.
The Journal of Allergy and Clinical Immunology|April 19, 2011
Genome-wide association identifies diverse causes of common variable immunodeficiencyJordan S Orange, Joseph T Glessner, Elena Resnick, et al.
British Journal of Haematology|October 11, 2011
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patientsDelphine Gobert, James B Bussel, Charlotte Cunningham-Rundles, et al.
Journal of Human Immunity|May 22, 2026
A systematic literature review of CVID reveals pervasive detrimental noninfectious manifestationsG Michelle Ducasa, Rebecca A Marsh, Ali Mojebi, et al.
Pageof 29